Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 10 04:00PM ET
114.76
Dollar change
-2.08
Percentage change
-1.78
%
Index- P/E- EPS (ttm)-9.34 Insider Own1.30% Shs Outstand56.61M Perf Week-14.79%
Market Cap6.58B Forward P/E- EPS next Y-3.51 Insider Trans0.00% Shs Float56.61M Perf Month-9.62%
Income-529.87M PEG- EPS next Q-1.42 Inst Own105.61% Short Float6.52% Perf Quarter-12.72%
Sales343.17M P/S19.18 EPS this Y19.43% Inst Trans3.64% Short Ratio9.07 Perf Half Y-22.55%
Book/sh-6.00 P/B- EPS next Y53.80% ROA-61.92% Short Interest3.69M Perf Year17.61%
Cash/sh4.83 P/C23.74 EPS next 5Y-1.02% ROE-867.62% 52W Range85.29 - 161.00 Perf YTD-8.88%
Dividend Est.- P/FCF- EPS past 5Y-19.87% ROI- 52W High-28.72% Beta0.67
Dividend TTM- Quick Ratio0.44 Sales past 5Y182.00% Gross Margin80.72% 52W Low34.56% ATR (14)5.69
Dividend Ex-Date- Current Ratio0.74 EPS Y/Y TTM17.33% Oper. Margin-111.43% RSI (14)23.42 Volatility5.68% 4.25%
Employees- Debt/Eq- Sales Y/Y TTM171.57% Profit Margin-154.40% Recom1.14 Target Price182.53
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q12.65% Payout- Rel Volume1.71 Prev Close116.84
Sales Surprise-56.76% EPS Surprise-30.53% Sales Q/Q-24.87% EarningsSep 03 AMC Avg Volume407.08K Price114.76
SMA20-14.37% SMA50-14.36% SMA200-14.47% Trades Volume696,032 Change-1.78%
Date Action Analyst Rating Change Price Target Change
Sep-05-24Upgrade Oppenheimer Perform → Outperform $180
Jun-25-24Upgrade TD Cowen Hold → Buy $156 → $175
May-31-24Initiated Stifel Buy $200
Dec-20-23Initiated Jefferies Buy $150
Jun-14-23Resumed Credit Suisse Neutral $89
Apr-05-23Downgrade Oppenheimer Outperform → Perform
Apr-04-23Downgrade Morgan Stanley Overweight → Equal-Weight $151 → $108
Apr-03-23Downgrade Credit Suisse Outperform → Neutral
Oct-20-22Initiated Goldman Buy $174
Aug-30-22Resumed Berenberg Buy $166
Sep-04-24 05:02PM
04:48PM
04:02PM
09:14AM
Sep-03-24 05:14PM
05:06PM Loading…
05:06PM
05:04PM
Sep-02-24 09:01AM
Aug-28-24 08:30AM
Aug-14-24 12:31PM
08:59AM
Aug-13-24 04:32AM
Aug-12-24 04:55PM
07:30AM
07:00AM
09:01AM Loading…
Jul-07-24 09:01AM
Jul-05-24 06:33AM
Jul-04-24 12:48PM
Jun-24-24 04:45PM
Jun-21-24 01:02AM
Jun-04-24 04:01PM
Jun-03-24 04:01PM
May-30-24 08:30AM
May-15-24 01:57PM
10:44AM
May-14-24 04:07PM
03:20PM
02:47PM
02:38PM
02:31PM
09:29AM Loading…
May-13-24 09:29AM
08:30AM
May-09-24 08:30AM
May-06-24 09:59AM
May-03-24 03:49AM
May-02-24 09:57PM
04:01PM
Apr-25-24 04:46PM
Apr-24-24 11:33AM
08:34AM
08:30AM
Apr-02-24 06:13AM
Mar-22-24 12:09PM
05:27AM
Mar-17-24 08:50AM
Mar-07-24 08:14AM
Mar-04-24 08:30AM
Feb-15-24 12:00PM
09:40AM
Feb-08-24 10:07AM
Feb-07-24 04:01PM
08:30AM
Feb-06-24 08:46AM
Jan-31-24 04:15PM
04:01PM
Jan-29-24 08:30AM
Jan-08-24 06:01PM
08:20AM
Jan-07-24 05:45PM
02:00PM
Dec-28-23 04:15PM
Dec-20-23 08:30AM
Dec-19-23 08:30AM
Dec-11-23 08:30AM
Nov-29-23 04:30AM
Nov-20-23 08:00AM
Nov-15-23 08:00AM
Nov-08-23 02:07PM
Nov-07-23 04:01PM
Nov-01-23 09:55AM
Oct-31-23 08:30AM
Oct-26-23 09:35AM
08:30AM
Oct-16-23 04:01PM
Oct-02-23 08:00AM
Sep-23-23 07:00AM
Sep-22-23 09:24AM
Sep-15-23 08:00AM
07:27AM
Sep-14-23 12:22PM
Sep-06-23 12:11PM
11:41AM
08:21AM
Sep-05-23 04:15PM
04:03PM
04:01PM
04:01PM
Aug-28-23 09:55AM
Aug-24-23 08:30AM
07:09AM
Aug-23-23 04:48PM
Aug-15-23 08:30AM
Aug-10-23 09:55AM
Aug-08-23 06:20AM
Jul-25-23 12:19AM
Jul-23-23 08:45AM
Jun-29-23 08:10AM
Jun-17-23 05:30PM
Jun-13-23 07:00AM
Jun-07-23 08:30AM
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.